Harpoon Therapeutics, Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible

    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.
    SEC MERCK SHARP & DOHME LLC N/A +21M $23.00 +$492.14M
    SEC Erbez Georgia Chief Financial Officer +10K $8.10 +$83.43K
    SEC UBS Oncology Impact Fund L.P. N/A -57K $20.63 -$1.19M
    SEC UBS Oncology Impact Fund L.P. N/A -17K $20.22 -$346.95K
    SEC UBS Oncology Impact Fund L.P. N/A -16K $20.18 -$321.00K
    SEC UBS Oncology Impact Fund L.P. N/A -48K $20.49 -$982.45K
    SEC UBS Oncology Impact Fund L.P. N/A -16K $20.05 -$329.24K
    SEC UBS Oncology Impact Fund L.P. N/A -68K $21.04 -$1.44M
    SEC UBS Oncology Impact Fund L.P. N/A -10K $22.52 -$229.07K
    SEC UBS Oncology Impact Fund L.P. N/A -329K $22.48 -$7.39M
    SEC UBS Oncology Impact Fund L.P. N/A -130K $21.99 -$2.86M
    SEC UBS Oncology Impact Fund L.P. N/A -9K $18.97 -$170.20K
    SEC UBS Oncology Impact Fund L.P. N/A -38K $19.04 -$726.41K
    SEC EVNIN LUKE N/A -4.7K $20.16 -$94.07K
    SEC UBS Oncology Impact Fund L.P. N/A -39K $20.16 -$777.29K
    SEC EVNIN LUKE N/A -13K $23.15 -$296.23K
    SEC UBS Oncology Impact Fund L.P. N/A -31K $21.90 -$677.32K
    SEC Erbez Georgia Chief Financial Officer +25K $2.12 +$53.00K
    SEC EVNIN LUKE N/A -183K $20.00 -$3.66M
    SEC EVNIN LUKE N/A -92K $20.06 -$1.84M
    SEC EVNIN LUKE N/A -120K $20.22 -$2.43M
    SEC EVNIN LUKE N/A -721K $20.02 -$14.44M
    SEC EVNIN LUKE N/A -170K $22.51 -$3.83M
    SEC HUNT RONALD N/A +235K $17.00 +$4.00M
    SEC New Leaf BPO Management II, L.L.C N/A +235K $17.00 +$4.00M
    SEC Erbez Georgia Chief Financial Officer +7.1K $11.46 +$81.34K
    SEC Erbez Georgia Chief Financial Officer +1.8K $10.92 +$19.84K
    SEC Arix Bioscience Holdings Ltd N/A -379K $21.37 -$8.09M
    SEC Sacks Natalie Chief Medical Officer -4.6K $12.06 -$54.95K
    SEC Erbez Georgia Chief Financial Officer +6.7K $14.09 +$94.40K
    SEC Baeuerle Patrick N/A -87K $15.98 -$1.40M
    SEC Arix Bioscience Holdings Ltd N/A -37K $17.01 -$621.85K
    SEC Chin Mark N/A -37K $17.01 -$621.85K
    SEC Arix Bioscience Holdings Ltd N/A -283K $17.75 -$5.03M
    SEC Chin Mark N/A -283K $17.75 -$5.03M
    SEC Erbez Georgia Chief Financial Officer +47K $2.12 +$100.26K
    SEC McMahon Gerald PhD President and CEO +169K $0.60 +$101.68K
    SEC McMahon Gerald PhD President and CEO +1K $10.16 +$10.16K
    SEC McMahon Gerald PhD President and CEO +1K $10.56 +$10.56K
    SEC McMahon Gerald PhD President and CEO +1K $10.53 +$10.53K
    SEC Arix Bioscience Holdings Ltd N/A +2.9M $14.00 +$40.49M
    SEC Chin Mark N/A +2.9M $14.00 +$40.49M
    SEC EVNIN LUKE N/A +4.2M $5.18 +$21.77M
    SEC Foley Todd N/A +4.2M $5.18 +$21.77M
    SEC GADICKE ANSBERT N/A +8.1M $6.65 +$53.87M
    SEC HUNT RONALD N/A +2.9M $14.00 +$40.90M
    SEC MPM Oncology Impact Management GP LLC N/A +3.9M $9.30 +$36.26M
    SEC New Leaf BPO Management II, L.L.C N/A +2.9M $14.00 +$40.90M

    Notifications